Skip to main content
Fig. 1 | Virology Journal

Fig. 1

From: Evaluation of SARS-CoV-2 neutralizing antibodies using a vesicular stomatitis virus possessing SARS-CoV-2 spike protein

Fig. 1

Characterization of pseudotyped viruses possessing spike proteins of SARS-CoV-2. a Incorporation or expression of S proteins in the virions or cells were investigated using CBB staining and immunoblotting. b Efficiency of gene transduction in various mammalian cell lines using the pseudotyped viruses. Sfullpv, St19pv, and 100-fold-diluted VSVpv generated in 293 T cells were inoculated into the indicated cell lines. At 24 h post-infection, infectivity of the viruses was determined by measuring luciferase activities as a relative luciferase unit (RLU). VSVpv without envelope (∆Gpv) was used as a negative control. The results are from three independent assays with error bars representing standard deviations

Back to article page

Virology Journal

ISSN: 1743-422X